Get started
Author

Linghui Xia

A bispecific CAR-T cell therapy targeting BCMA and CD38 in relapsed or refractory multiple myeloma
2021 · Heng Mei, Chenggong Li, et al. · Journal of Hematology & Oncology · 221
PDF
Consensus on the monitoring, treatment, and prevention of leukaemia relapse after allogeneic haematopoietic stem cell transplantation in China: 2024 update
2024 · Yu Wang, Ying-Jun Chang, et al. · Cancer Letters · 139
Haplo‐identical transplantation for acquired severe aplastic anaemia in a multicentre prospective study
2016 · Lan‐Ping Xu, Shun‐Qing Wang, et al. · British Journal of Haematology · 139
PDF
Hematopoietic stem cell transplantation activity in China 2019: a report from the Chinese Blood and Marrow Transplantation Registry Group
2021 · Lan-Ping Xu, Pei-Hua Lu, et al. · Bone Marrow Transplantation · 87
PDF
Comparable long-term outcomes between upfront haploidentical and identical sibling donor transplant in aplastic anemia: a national registry-based study
2022 · Zheng-Li Xu, Lan-Ping Xu, et al. · Haematologica · 66
PDF
Basiliximab for steroid‐refractory acute graft‐versus‐host disease: A real‐world analysis
2022 · Xiao‐Dong Mo, Shen‐Da Hong, et al. · American Journal of Hematology · 54
Neurological toxicities and coagulation disorders in the cytokine release syndrome during CAR‐T therapy
2017 · Heng Mei, Huiwen Jiang, et al. · British Journal of Haematology · 49
PDF
Current Treatment Patterns of Aplastic Anemia in China: A Prospective Cohort Registry Study
2019 · Xiao-Fan Zhu, Hai-Long He, et al. · Acta Haematologica · 41
Efficacy and safety of the C5 inhibitor crovalimab in complement inhibitor‐naive patients with PNH ( COMMODORE 3): A multicenter, Phase 3, single‐arm study
2023 · Hui Liu, Linghui Xia, et al. · American Journal of Hematology · 38
PDF
Nanopore-Targeted Sequencing Improves the Diagnosis and Treatment of Patients with Serious Infections
2023 · Yi Zhang, Xuan Lu, et al. · mBio · 38
PDF
Hematopoietic Stem Cell Transplantation Activity in China 2020–2021 During the SARS-CoV-2 Pandemic: A Report From the Chinese Blood and Marrow Transplantation Registry Group
2022 · Lan-Ping Xu, Dao-Pei Lu, et al. · Transplantation and Cellular Therapy · 31
Hematopoietic stem cell transplantation activity in China 2022–2023. The proportions of peripheral blood for stem cell source continue to grow: a report from the Chinese Blood and Marrow Transplantation Registry Group
2024 · Lan-Ping Xu, Pei-Hua Lu, et al. · Bone Marrow Transplantation · 29
The application of nanopore targeted sequencing in the diagnosis and antimicrobial treatment guidance of bloodstream infection of febrile neutropenia patients with hematologic disease
2023 · Mei Hong, Danyue Peng, et al. · Journal of Cellular and Molecular Medicine · 24
Co-transplantation of mesenchymal stem cells makes haploidentical HSCT a potential comparable therapy with matched sibling donor HSCT for patients with severe aplastic anemia
2020 · Zenghui Liu, Xiaoxiong Wu, et al. · Therapeutic Advances in Hematology · 22
Elevated Fas/FasL system and endothelial cell microparticles are involved in endothelial damage in acute graft-versus-host disease: A clinical analysis
2011 · Qiuling Wu, Huixin Chen, et al. · Leukemia Research · 21
Decitabine-Intensified Modified Busulfan/Cyclophosphamide Conditioning Regimen Improves Survival in Acute Myeloid Leukemia Patients Undergoing Related Donor Hematopoietic Stem Cell Transplantation: A Propensity Score Matched Analysis
2022 · Ziying Li, Wei Shi, et al. · Frontiers in Oncology · 17
PDF
Idarubicin-intensified BUCY2 regimens may lower relapse rate and improve survival in patients undergoing allo-SCT for high-risk hematological malignancies: a retrospective analysis
2011 · M Hong, Q Wu, et al. · Bone Marrow Transplantation · 17
Mangiferin Promotes Bregs Level, Activates Nrf2 Antioxidant Signaling, and Inhibits Proinflammatory Cytokine Expression in Murine Splenic Mononuclear Cells In Vitro
2021 · Zhi-zhi Qin, Jun Ruan, et al. · Current Medical Science · 15
Reduced-intensity versus Myeloablative Conditioning Regimens for Younger Adults with Acute Myeloid Leukemia and Myelodysplastic Syndrome: A systematic review and meta-analysis
2020 · Shengling Ma, Wei Shi, et al. · Journal of Cancer · 14
PDF
Evaluation of different scoring systems and gene mutations for the prognosis of myelodysplastic syndrome (MDS) in Chinese population
2019 · Meng-yi Du, Min Xu, et al. · Journal of Cancer · 14
PDF
SIRT5 inhibition impairs mitochondrial metabolism and enhances venetoclax-induced elimination of acute myeloid leukemia cells
2025 · Moran Wang, Ruiqi Zhu, et al. · Leukemia · 12
PDF
A Novel Risk Predictive Scoring Model for Predicting Subsequent Infection After Carbapenem-Resistant Gram-Negative Bacteria Colonization in Hematological Malignancy Patients
2022 · Qiuling Wu, Chenjing Qian, et al. · Frontiers in Oncology · 12
PDF
Role of Radiation Therapy Differs Between Stages in Primary Bone Large B-Cell Lymphoma in Rituximab Era: A Population-Based Analysis
2020 · Shengling Ma, Yuanyuan Zhang, et al. · Frontiers in Oncology · 12
PDF
Lower dose of ATG combined with basiliximab for haploidentical hematopoietic stem cell transplantation is associated with effective control of GVHD and less CMV viremia
2022 · Zhenli Huang, Han Yan, et al. · Frontiers in Immunology · 11
Efficacy and safety of Orelabrutinib-based regimens in diffuse large B-cell lymphoma: a single-center retrospective analysis
2023 · Ruowen Wei, Yingying Wu, et al. · Clinical and Experimental Medicine · 10
PDF
Works count: 87
Citation count: 1,305
H-index: 17
I10-index: 27
Year
Topic
Type